SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Highlands complete one of “largest legal shipments” of cannabis to Europe

    By

    Highland Investments has completed the 8.5 tonne shipment of certified medical cannabis into Europe, which the company says is one of the largest legal shipments to date.

    The licensed cultivator of high-quality Good Agricultural Practice (GAP) and ISO 22000 certified cannabis, Highland Investments, has secured the sale of its Highlands Pure THC and CBD flower and trim into the European medical cannabis market.

    The cannabis was shipped from its outdoor cannabis cultivation facility in Lesotho, Africa, and follows a previous shipment of 176.5kg of THC flower to Europe in April.

    One of the largest shipments to date

    The shipment made up the remainder of Highland’s 2021 harvest and comprised just over 2,000kg of THC and 6,500kg of CBD flower and trim.

    Highland Investments managing director, Mark Corbett, commented: “We believe this to be one of the largest legal shipments of medical-grade cannabis to date and is a significant milestone for our business. Our cannabis is GAP and ISO 22000 certified with a proven supply chain into the much-coveted European medical cannabis market. 

    “…The size of the shipment, which is enough to fill almost four 40 foot containers, required a chartered plane to transport to Macedonia.

    “The rapidly growing global medical, wellness and consumer cannabis markets all increasingly require certified, high-quality flower to meet their expanding product portfolios. We are fortunate that we have some of the most competitive cost per hectare metrics and this, together with our ISO 22000 certification and proven route to market, firmly entrenches Highlands as the partner of choice in this competitive space.

    “With demand for quality cannabis growing, we are now in the process of extending our Highlands Pure range of products to include GMP certified distillates, isolates and crude, these products will be available on the global market from quarter 4 2021.”

    [activecampaign form=31]

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.